GSVRX
Price
$16.06
Change
+$0.05 (+0.31%)
Updated
Sep 18 closing price
Net Assets
433.43M
VVIAX
Price
$72.48
Change
+$0.25 (+0.35%)
Updated
Sep 18 closing price
Net Assets
202.84B
Interact to see
Advertisement

GSVRX vs VVIAX

Header iconGSVRX vs VVIAX Comparison
Open Charts GSVRX vs VVIAXBanner chart's image
Goldman Sachs Large Cap Value R
Price$16.06
Change+$0.05 (+0.31%)
VolumeN/A
Net Assets433.43M
Vanguard Value Index Adm
Price$72.48
Change+$0.25 (+0.35%)
VolumeN/A
Net Assets202.84B
GSVRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSVRX vs. VVIAX commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GSVRX (433M). VVIAX pays higher dividends than GSVRX: VVIAX (2.10) vs GSVRX (0.75). GSVRX was incepted earlier than VVIAX: GSVRX (18 years) vs VVIAX (25 years). GSVRX (1.50) is less costly to investors than VVIAX (0.05). GSVRX is a more actively managed with annual turnover of: 51.00 vs. VVIAX (9.00). GSVRX has a lower initial minimum investment than VVIAX: GSVRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.55 vs. GSVRX (-4.17). VVIAX return over 5 years is better than : 74.26 vs. GSVRX (24.74).
GSVRXVVIAXGSVRX / VVIAX
Total Expense Ratio1.250.052,500%
Annual Report Gross Expense Ratio1.500.053,000%
Fund Existence18 years25 years-
Gain YTD6.3799.42568%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets433M203B0%
Annual Yield % from dividends0.752.1036%
Returns for 1 year-4.177.55-55%
Returns for 3 years13.4638.1035%
Returns for 5 years24.7474.2633%
Returns for 10 years9.57137.777%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBAT0.910.04
+4.36%
CBAK Energy Technology
ARQT17.710.57
+3.33%
Arcutis Biotherapeutics
RYAM7.130.18
+2.59%
Rayonier Advanced Materials
APDN2.930.03
+1.03%
Applied DNA Sciences Inc
WLK84.96-2.00
-2.30%
Westlake Corp